PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia · Delayed Price · Currency is IDR 284.00
-4.00 (-1.39%)
Last updated: May 20, 2026, 10:12 AM WIB
IDX:OBAT Revenue
In the year 2025, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 160.12B IDR with 32.74% growth. PT Brigit Biofarmaka Technologi Tbk had revenue of 45.37B in the quarter ending December 31, 2025, with 45.58% growth.
Revenue
160.12B
Revenue Growth
+32.74%
P/S Ratio
1.08
Revenue / Employee
7.28B
Employees
22
Market Cap
172.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 160.12B | 39.49B | 32.74% |
| Dec 31, 2024 | 120.63B | 63.70B | 111.89% |
| Dec 31, 2023 | 56.93B | 18.43B | 47.89% |
| Dec 31, 2022 | 38.50B | 642.48M | 1.70% |
| Dec 31, 2021 | 37.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Wahana Pronatural Tbk | 1.57T |
| PT Indo Oil Perkasa Tbk | 1.04T |
| PT Panca Mitra Multiperdana Tbk | 658.10B |
| PT Indo American Seafoods Tbk | 638.80B |
| PT Toba Surimi Industries Tbk | 608.51B |
| PT Morenzo Abadi Perkasa Tbk | 379.12B |
| PT Formosa Ingredient Factory Tbk | 178.40B |
| PT Maxindo Karya Anugerah Tbk | 141.54B |